Summary:
Comprehensive Assessment of Erenumab Efficacy in Subjects With High Frequency Episodic Migraine
Qualified Participants Must:
• 18 Years of age and older
•
Documented History of Migraines
•
4 or more migraines per month
Qualified Participants May Receive:
Study Medical Care At No Cost
Study Medication At No Cost
Compensation for time and travel